Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma.
Jeong H, Im HS, Bang Y, Kim YH, Kim HR, Lee HJ, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Lee JH, Ahn JY, Na HK, Ryu JS, Kang J, Kim SB, Kim JH, Park SR. Jeong H, et al. Among authors: park sr. Cancer Med. 2021 Mar;10(5):1745-1758. doi: 10.1002/cam4.3783. Epub 2021 Feb 15. Cancer Med. 2021. PMID: 33590710 Free PMC article.
A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.
Kim YW, Kim MJ, Ryu KW, Lim HS, Lee JH, Kong SY, Lee JS, Choi IJ, Kim CG, Lee JY, Cho SJ, Kook MC, Park YI, Kim SK, Park SR. Kim YW, et al. Among authors: park yi, park sr. Gastric Cancer. 2016 Apr;19(2):586-596. doi: 10.1007/s10120-015-0490-3. Epub 2015 Apr 8. Gastric Cancer. 2016. PMID: 25851942 Clinical Trial.
Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1).
Park SR, Park YS, Ryu MH, Ryoo BY, Woo CG, Jung HY, Lee JH, Lee GH, Kang YK. Park SR, et al. Among authors: park ys. Eur J Cancer. 2016 Jan;53:42-50. doi: 10.1016/j.ejca.2015.09.018. Epub 2015 Dec 13. Eur J Cancer. 2016. PMID: 26693898
A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine.
Lee KW, Kim BJ, Kim MJ, Han HS, Kim JW, Park YI, Park SR. Lee KW, et al. Among authors: park yi, park sr. Cancer Res Treat. 2017 Jul;49(3):706-716. doi: 10.4143/crt.2016.216. Epub 2016 Oct 18. Cancer Res Treat. 2017. PMID: 27764906 Free PMC article. Clinical Trial.
726 results